氧化纳米颗粒对黄金葡萄球菌的抗菌活性进展 (综述)
Yuqing Hao1, Yadong Wang2, Li Zhang3
1Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.
Biomedical reports
|September 13, 2024
概括
氧化纳米颗粒 (ZnO NPs) 显示出针对金黄色葡萄球菌 (S. aureus) 的显著抗菌活性. 本综述涵盖了各种合成方法,与抗生素的协同作用,以及基于ZnO NP的材料的增强活动.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 微生物学 微生物学
背景情况:
- 细菌感染,特别是由黄金葡萄球菌引起的,构成了全球重大健康挑战.
- 纳米粒子 (NP),特别是金属和金属氧化物NP,提供了对抗细菌病原体的有前途的治疗策略.
- 氧化纳米颗粒 (ZnO NPs) 由于其强大的抗菌特性而成为一个关键焦点.
研究的目的:
- 综合审查ZnO NPs对黄金葡萄球菌的抗菌活性.
- 总结通过各种方法合成的ZnO NPs的发现,重点是绿色合成.
- 探索ZnONP与抗生素的协同作用以及基于ZnO的纳米复合材料的增强活性.
主要方法:
- 对研究ZnO NPs针对S. aureus的研究进行文献综述.
- 分析各种ZnO NP合成技术,包括绿色合成方法.
- 对涉及ZnONP和抗生素的联合疗法研究的审查.
- 对ZnO纳米复合材料,纳米混合物和功能化ZnONP的研究的评估.
主要成果:
- ZnO NPs通过多种机制表现出强大的抗菌作用,对金黄色细菌产生强烈的抗菌作用.
- 绿色合成的 ZnO NPs 显示出类似或更高的抗菌效果.
- 当ZnONP与常规抗生素结合时,可以观察到协同作用的抗菌作用.
- ZnO纳米复合材料,纳米混合物和功能化的 ZnO NPs 显示出增强的抗菌性能.
结论:
- ZnO NPs代表了一种针对S. aureus的多功能和有效的抗菌剂.
- 绿色合成为生产抗菌ZnONP提供了可持续和高效的途径.
- 组合疗法和先进的ZnO NP配方在对抗金菌感染方面具有很大的前景.
相关概念视频
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:24Microbial Corrosion
Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...